SOP 903: HRPP AND NON-COMPLIANCE

Similar documents
Institutional Review Board Standard Operating Procedure. Suspension and Termination of IRB Approval

Michigan State University Human Research Protection Program

Yale University Human Research Protection Program

NONCOMPLIANCE. 1. Overview

SYRACUSE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM STANDARD OPERATING PROCEDURES

SOP 801: Investigator Qualifications and Responsibilities

CUNY HRPP Policy: Suspension or Termination of Human Subject Research

University of Wisconsin Colleges Administrative Policy #56 NON-COMPLIANCE IN HUMAN SUBJECTS RESEARCH

UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONTINUING REVIEW AND REAPPROVAL OF RESEARCH

UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD CONTINUING REVIEW OF RESEARCH

Wayne State University Institutional Review Board

Issue in IRB Approvals:

SOP 407: PROTOCOL DEVIATIONS AND UNANTICIPATED PROBLEMS

CONTINUING REVIEW CRITERIA FOR RENEWAL

Administrative Hold, Suspension, or Termination of IRB Approval

Procedure Department: HUMAN RESEARCH PROTECTIONS PROGRAM Policy Number: II.B.1

Reporting an Unanticipated Problem Involving Risks to Subjects or Others (UPIRTSO) to the IRB

CONTINUING REVIEW 3/7/2016

To assure knowledge and compliance by documenting the annual administrative review and continuing IRB review of non-exempt projects for the IRB.

COMPLIANCE MONITORING

CONTINUING REVIEW OF APPROVED IRB PROTOCOLS

IOWA STATE UNIVERSITY Institutional Review Board. Policy on IRB Review of Protocol Deviations and Noncompliance for Non-exempt Research

the HRPP Director will prepare a draft report within three (3) workdays after the IRB meeting at which the determination occurred.

CONTINUING REVIEW CRITERIA FOR RENEWAL

Effective Date Revisions Date Review by the Convened Institutional Review Board

University of Iowa External/Central IRB Reliance Process Standard Operating Procedure (SOP)

SUSPENSION OR TERMINATION OF HUMAN SUBJECTS RESEARCH

2 Institutional Review Board

Human Research Protection Program Policy

Institutional Responsibilities Under A Federalwide Assurance

SOP 5.06 Full Committee Review: Initial IRB Review

2.0 Institutional Review Board

Florida State University IRB Standard Operational Procedures

Independent Ethics Committees

Review of Research by the Convened IRB

Signature Date Date First Effective: Signature Date Revision Date: 07/18/2011

The Children s Hospital of Philadelphia Committee for the Protection of Human Subjects Policies and Procedures. Cooperative Agreements

UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD PROCEDURES FOR FULL BOARD REVIEW

Section 8. Continuing Review of Ongoing IRB-Approved Research (Revised 7/1/10)

IRB MEETING ADMINISTRATION

Chapter 4 Institutional Review Board (IRB) Roles and Authorities

Guidance for IRBs, Clinical Investigators, and Sponsors IRB Continuing Review after Clinical Investigation Approval

To assure knowledge and compliance by documenting the continuing review procedure of approved projects for the IRB.

Supersedes Document Dated: 7/7/11. SOP: RR 401 Version No.: 07 Version Date: 9/8/15 EXPEDITED REVIEW 1. POLICY

Signature Date Date First Effective: Signature Date Revision Date:

Illinois Institute of Technology Institutional Review Board Handbook of Procedures for the Protection of Human Research Subjects

Collaborative Research

Initial Review. Approved By: Michele Kennett, JD, MSN, LLM Associate Vice Chancellor for Research. Table of Contents

I. Summary. II. Responsibilities

Research Involving Human Subjects: AA 110.7

OHRP Guidance on Written IRB Procedures

Yale University Institutional Review Boards

EXPEDITED REVIEW. Terms used in this policy, but not defined herein shall have the meanings set forth in the Glossary.

INSTITUTIONAL REVIEW BOARD POLICY

Ceded IRB Review. The project involves prisoners or other vulnerable populations that require special considerations.

PRINCIPAL INVESTIGATOR S ACKNOWLEDGMENT OF RESPONSIBILITIES

POLICY NO EXEMPT RESEARCH... 4 POLICY NO DISCLOSURE OF RESEARCH LAB TEST RESULTS... 5

INSTITUTIONAL REVIEW BOARD MANUAL: PURPOSE and POLICIES.

Oklahoma State University Institutional Review Board Standard Operating Procedures

INSTITUTIONAL REVIEW BOARD (IRB) PROCEDURES

Version 1. Submission Guide and Policies

EMERGENCY USE 03/02/2016

Effective Date: January 16, 2012 Policy Number: MHC_RP0107. Revised Date: November 2, 2015 Oversight Level: Corporate

AUTHORITY AND PURPOSE

Institutional Review Board - Restriction s Impo sed

IRB Chair Responsibilities

Lapse in IRB Approval

IV. Basic Procedures for Human Research Protections

Tuesday, May 15, Please be sure to sign in and take copies of each handout.

HSPP Standard Operating Procedures

SYRACUSE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM STANDARD OPERATING PROCEDURES 02 06/30/10 08/01/07 1 OF 6

Your Roadmap to Single IRB Review Serving as a Reviewing IRB

AMENDMENTS TO PREVIOUSLY APPROVED RESEARCH 3/01/2016

The Top 10 Human Research Protection Compliance Risks

Policy Number: 42 Title: Investigational Devices Date of Last Revision: 06/12/2008; 07/22/2010; 05/29/2013; 05/01/2016; 10/16/2018

Tarleton State University

SOP #2-2 Version #1 Date First Effective: December 14, Page 1 of 6

INSTITUTIONAL REVIEW BOARD (IRB) PROCEDURES

Standard Operating Policy and Procedures (SOPP) 3:

STRUCTURE, MANAGEMENT AND COMPOSITION OF IRBS Chapter 6

I. Summary. II. Responsibilities

Institutional Review Board (IRB) Policies and Procedures Manual

IRB Authorization Agreement Implementation Checklist and Documentation Tool

Title: EXPEDITED IRB REVIEW OF HUMAN SUBJECTS RESEARCH

IRB MEETING ADMINISTRATION

CUNY HRPP Procedures: Multisite Non-Exempt Human Subjects Research

University of Cincinnati. Radiation Safety Committee Operations Guidelines Statement of Policy (RSC Guidelines) RSC Guidelines (revision 5)

IRB HANDBOOK April 2010

Institutional Review Board (IRB) Non-affiliated Member Nomination

November 30, Efficient Startup of Multi-site Research Studies: Central IRBs and National IRB Reliance Platforms

7.0 DEVIATION and EXCEPTION of a PREVIOUSLY APPROVED PROTOCOL

Signature Date Date First Effective: Signature Date Revision Date: 05/14/2014

IRB MEMBERSHIP COMPOSITION, ROLES AND RESPONSIBILIES

21 CFR Part 56 - Institutional Review Boards

Children s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures Continuing Review of Approved Research

Category Description This policy and procedure applies to the Sparrow research community.

Food and Drug Administration Center for Devices an d * 1Ya I a Radiological Health WARNING LETTE R

Institutional Review Board

USC Institutional Review Boards (IRBs)

THE UNIVERSITY OF SOUTH DAKOTA -- INSTITUTIONAL REVIEW BOARD -- STANDARD OPERATING PROCEDURES

Transcription:

SOP 903: HRPP AND NON-COMPLIANCE DEFINITIONS a) Non- b) Serious Non- c) Continuing Non- Failure to abide by the policies, requirements, and determination of the IRB, or federal rules and regulations including the requirements of the VHA Handbook 1200.5 governing human subject research. An act or omission to act that resulted in significant harm (physical, psychological, safety, or privacy) or significantly increased the possibility of harm to the rights and welfare of research participants. A pattern of repeated actions or omissions to act that suggests a future likelihood of reoccurrence and that indicates a deficiency in the ability or willingness to comply with Federal regulations, VA Handbook 1200.5 or the policy, requirements, and determinations of the IRB governing human subject research. d) Allegation An assertion made by a party that must be proved or supported with evidence. e) Confirmed Report f) Research Misconduct Alleged non compliance which in the judgment of the IRB administrator, IRB Chair or IRB Vice-Chair is factual. Any fabrication, falsification, or plagiarism in proposing, performing, or reviewing research or reporting research results. Instances meeting the definition of research misconduct will be reported to the Associate Vice President for Research Integrity by the IRB Director, IRB Chair, or IRB Vice-Chair. Attempts to unduly influence an IRB member or IRB staff is not considered research misconduct under federal or University of Utah policy. However, this is considered a violation of University of Utah IRB policy. IRB members or staff members who believe that they have been subject to undue influence must report this to the Associate Vice President of Research Integrity or IRB Director, IRB Chair or Vice-Chair, or the VA Facility Director. The IRB Director, IRB Chair or IRB Vice-Chair will report all allegations of undue influence to the Vice President for Research Integrity, who will coordinate the inquiry, investigation and hearing phases as needed. Page 1 of 5

All investigations and reporting will be conducted according to the University of Utah Policy for Research Misconduct http://www.admin.utah.edu/ppmanual/6/6-1-1.html. POLICY It is the policy of the University of Utah to address both allegations and confirmed reports of any noncompliance in accordance with 45 CFR Part 46 and 21 CFR Part 50 the policies, requirements and determinations of the IRB and the VHA Handbook 1058.01 (Research Reporting Requirements. This policy applies to the research investigative team, the IRB and IRB staff. Members of the research community must report apparent non-compliance to the IRB. The determination that non-compliance is serious or continuing rests with the IRB. 1. Procedures for Addressing Allegations of Non- Allegations of non-compliance are investigated by an IRB administrator, the IRB Chair, or a designated IRB Vice-Chair. 1.1. The IRB administrator conducts a pre-inquiry review for preliminary informal checking of the facts to determine if there is a reasonable basis for the allegation and if the allegation can be supported or proved by the evidence. If the allegation of non-compliance is determined by the IRB administrator not to be a credible confirmed report of non-compliance in fact by definition, the inquiry stops and no further action is taken. If the allegation of non-compliance is determined by the IRB administrator to be a credible, confirmed report of non-compliance in fact by definition, the inquiry proceeds as outlined in this policy. The allegation of non-compliance is considered a confirmed report of noncompliance by definition. 2. Procedures for Addressing Confirmed Reports of Non- The IRB administrator reviews the confirmed report of non-compliance. 2.1. The IRB administrator determines whether the confirmed report of non-compliance either does not represent serious or continuing non-compliance or might represent serious or continuing non-compliance as defined in this policy. 2.1.1. If the IRB administrator determines that the confirmed report of non-compliance is neither serious nor continuing non-compliance, as defined by this policy, the IRB administrator or designee considers but is not limited to the following actions: Acknowledgement of the problems, requiring no sanctions but with instructions of the necessity to establish procedures and policies to avoid further infractions. Page 2 of 5

2.1.2. If the IRB administrator determines that the confirmed report of non-compliance might be either serious or continuing non-compliance, as defined by this policy, the IRB administrator refers the confirmed report of non-compliance to the IRB Chair or IRB Vice- Chair with his/her evaluation. At the discretion of the IRB administrator, he/she may refer the confirmed report of non-compliance to the convened IRB with his/her evaluation (skip to 2.3 for procedures to be followed in this case). 2.2. The IRB Chair or IRB Vice-Chair reviews the confirmed report of non-compliance. 2.2.1. If the IRB Chair or IRB Vice-Chair determines that more information is needed because the inquiry discloses a reasonable basis for concern that significant infractions have occurred, he/she directs further investigation by the IRB administrator. The investigator is notified in writing of the directed investigation by the IRB administrator or designee. 2.2.2. The IRB Chair or IRB Vice-Chair determines whether the confirmed report of noncompliance either does not represent serious or continuing non-compliance or might represent serious or continuing non-compliance as defined in this policy. 2.2.3. If the IRB Chair or IRB Vice-Chair determine that the confirmed report of non-compliance is neither serious non-compliance nor continuing non-compliance, as defined by this policy, the IRB Chair or IRB Vice-Chair considers but is not limited to the following actions: Acknowledgement of the problems, requiring no sanctions but with instructions of the necessity to establish procedures and policies to avoid further infractions. 2.2.4. If the IRB Chair or IRB Vice-Chair determines that the confirmed report of non-compliance might be serious non-compliance or continuing non-compliance, as defined by this policy, the IRB Chair or IRB Vice-Chair refers the confirmed report of non-compliance to the convened IRB with his/her evaluation. 2.3. When issues of non-compliance are reviewed by the convened IRB, the IRB staff prepares the documents listed below, if they apply, and makes them available to all members of the convened IRB for review three working days prior to the meeting, either in ERICA or in paper form. All IRB members are expected to review the information and be prepared to discuss it at the meeting. The current ERICA application; The Informed Consent Document; The Investigator Brochure; The confirmed report of non-compliance; Page 3 of 5

The audit report (investigation report) including a list of witnesses and documents reviewed; Previous reports of non-compliance and the past record of the investigator and his/her team; The evaluation of the confirmed report of non-compliance by IRB Chair or IRB Vice-Chair; All additional pertinent documents or portions thereof (e.g., primary data). 2.4. An IRB staff member assigns a primary reviewer based on scientific expertise to perform an indepth review of the documents. The primary reviewer will present his/her findings. The primary reviewer and the IRB Chair or IRB Vice-Chair will lead the discussion during the convened IRB meeting. 2.5. For VA Research: The IRB Chair or designee must consult the relevant Office of Research Oversight (ORO) Regional Office (RO) if the significance of a reported event is not clear. 2.6. The convened IRB votes on whether the confirmed report of non-compliance represents serious non-compliance or continuing non-compliance as defined by this policy. IRB staff records the discussion, rationale for any action and vote in the minutes. 2.7. If the convened IRB determines that the confirmed report of non-compliance is neither serious non-compliance nor continuing non-compliance, as defined by this policy, the IRB considers but is not limited to the following actions: Acknowledgement of the problems, requiring no sanctions but with instructions of the necessity to establish procedures and policies to avoid further infractions. 2.8. If the convened IRB determines the confirmed report of non-compliance represent serious non-compliance or continuing non-compliance, as defined by this policy, the IRB considers but is not limited to the following actions: Verification that participant selection is appropriate. Observation of the research and the informed consent process by an IRB administrator. Modifications of the protocol. Request an increase in monitoring of the research activity via an independent data safety monitor or board. Safety intervention as necessary such as visits to the activity site and continuing evaluation of the site by an IRB administrator. Request audit and progress reports from the sponsor monitor or CRO. Request a directed audit of targeted areas of concern by an IRB administrator. Request a status report after each participant receives intervention from the Investigator. Modify the frequency of the continuing review cycle. Request additional Investigator and staff education focused on human research protections from appropriate available sources (e.g., GCP Training, OHRP conferences, NIH tutorial, human research protections seminars). Page 4 of 5

Notify current subjects, if the information about the non-compliance might affect their willingness to continue participation. Provide additional information to past participants. Suspend IRB approval of the respective study pending a written plan for the correction and /or prevention of the non-compliance. Remove the Principal Investigator of the research study. Suspend or terminate some or all of the research study and possibly other studies being conducted by the Principal Investigator as well (See IRB SOP 904 for suspension and termination procedures and IRB SOP 905 for reporting procedures). 2.9. If the IRB determines that the confirmed report of non-compliance was either serious noncompliance or continuing non-compliance, as defined by this policy, the matter is referred to the IRB staff to handle according to SOP 905, Reporting Procedures. Page 5 of 5